Browsing Centre for Clinical Pharmacology by Subject "Non-ST Elevated Myocardial Infarction"

Now showing items 1-3 of 3

    • EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. 

      Chieffo, A; Stefanini, GG; Price, S; Barbato, E; Tarantini, G; Karam, N; Moreno, R; Buchanan, GL; Gilard, M; Halvorsen, S (2020-05-14)
      The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to healthcare worldwide. The infection can be life threatening and require intensive care treatment. The transmission of the disease poses ...

    • Sex disparities in acute myocardial infarction care and outcomes. 

      Gul, B; Kozuma, K; Haimi, I; Zhao, W; Simonton, C; Ying, S-W; Buda, A; Mehta, S; Baumbach, A; Lansky, A (2018-11-01)
      AIM: We investigated sex-based and regional outcomes after contemporary percutaneous coronary intervention (PCI) with the Xience V stent in patients with acute myocardial infarction (AMI). METHODS AND RESULTS: This patient ...

    • Validation of the all-comers design: Results of the TARGET-AC substudy. 

      G Toth, G; Lansky, A; Baumbach, A; Kelbæk, H; van Royen, N; Holmvang, L; Janssens, L; Brugaletta, S; Barbato, E; Maillard, L (2020-03)
      BACKGROUND: Results of clinical trials are often criticized by low inclusion rate and potential sampling bias in patient recruitment. The aim of this validation registry is to evaluate how far an all-comers design in the ...